The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Australia and New Zealand (ANZ) outcomes of high-dose chemotherapy and stem cell transplantation for relapsed or refractory germ cell tumors (GCT) from 1999 to 2019: Multicenter registry-based study with ABMTRR.
 
Elizabeth Anne Connolly
Travel, Accommodations, Expenses - cerner
 
Andrew James Weickhardt
Honoraria - Eisai; Merck Sharp & Dohme
Consulting or Advisory Role - Bristol-Myers Squibb; Merck Sharp & Dohme
Speakers' Bureau - Astellas Pharma
Research Funding - Merck
Travel, Accommodations, Expenses - Astellas Pharma; Ipsen; Merck Sharp & Dohme
 
Peter S. Grimison
Research Funding - ASLAN Pharmaceuticals (Inst); Boston Biomedical (Inst); Eisai (Inst); Five Prime Therapeutics (Inst); Genentech (Inst); Gilead Sciences (Inst); Halozyme (Inst); Janssen-Cilag (Inst); Medimmune; MSD (Inst); Pfizer (Inst); Pfizer (Inst); QED Therapeutics (Inst); Specialised Therapeutics (Inst); Tigermed (Inst); Tilray (Inst)
 
Gillian Heller
No Relationships to Disclose
 
Jeremy Howard Lewin
Consulting or Advisory Role - Bayer (Inst)
 
Elizabeth Chien Hern Liow
Travel, Accommodations, Expenses - Pfizer
 
Iris Tung
No Relationships to Disclose
 
Ben Tran
Honoraria - Amgen; Astellas Pharma; Janssen-Cilag; Sanofi; Tolmar
Consulting or Advisory Role - Amgen; Astellas Pharma; Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb; Ipsen; Ipsen; Janssen-Cilag; MSD Oncology; Sanofi; Tolmar
Research Funding - Amgen (Inst); Astellas Pharma (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb; Genentech (Inst); Janssen-Cilag (Inst); Janssen-Cilag (Inst); Merck Sharp & Dohme; Merck Sharp & Dohme; Pfizer (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Amgen; Astellas Pharma
 
Sean Hill
No Relationships to Disclose
 
Euan Thomas Walpole
Consulting or Advisory Role - Novartis
Research Funding - MSD Oncology (Inst); Novartis (Inst); Roche (Inst)
 
Jane McKenzie
No Relationships to Disclose
 
Anna Kuchel
No Relationships to Disclose
 
Garry Forgeson
No Relationships to Disclose
 
Alvin Boon Tee Tan
Honoraria - Research Review
 
Abhishek Joshi
No Relationships to Disclose
 
Alistair Wickham
No Relationships to Disclose
 
Thean Hsiang Tan
Speakers' Bureau - Ipsen; Janssen Oncology
 
Yang Wang
No Relationships to Disclose
 
Nada Hamad
No Relationships to Disclose
 
Vanessa Wong
Research Funding - Amgen (Inst); Merck (Inst); Novartis (Inst); Roche (Inst)